GOSSAMER BIO INC (GOSS) Stock News
NASDAQ:GOSS - Nasdaq - US38341P1021 - Common Stock - Currency: USD
GOSS Latest News, Press Relases and Analysis
Peabody pauses seeking debt for partial refinance of $2.1bn private loan
The pause came after the planned acquisition of Anglo American's coal business went under review.
Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?
We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against other biotech penny stocks. Peter Marks’s departure from the FDA has left innovators concerned regarding the current state of the […]
Is Ecarx Holdings Inc. (NASDAQ:ECX) the Best Penny Stock to Invest in Under $1?
We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look at where Ecarx Holdings Inc. (NASDAQ:ECX) stands against other penny stocks to invest in under $1. Earlier on February 12 this year, Chief Investment Officer at Cetera Financial Group, […]
GOSS Stock Earnings: Gossamer Bio Misses EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gossamer Bio (NASDAQ:GOSS) just reported results for the second quarter of 2024...
Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?
We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look at where Gossamer Bio Inc. (NASDAQ:GOSS) stands against other penny stocks to invest in under $1. Earlier on February 12 this year, Chief Investment Officer at Cetera Financial Group, […]
Coinbase price target lowered to $275 from $390 at Monness Crespi
Monness Crespi lowered the firm’s price target on Coinbase (COIN) to $275 from $390 and keeps a Buy rating on the shares. Coinbase “still has cyclicality to it,’ but its ability to remain profitable means the stock’s multiple can begin to expand prior to earnings troughing, the analyst tells investors in a research note. The firm believes the company’s opportunity for total addressable market expansion and real-world utility “remain in play.” Published first on TheFly – the ultimate source for r
Relay Therapeutics, Inc. (RLAY): Among Stocks Under $10 that Will Triple
We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Relay Therapeutics, Inc. (NASDAQ:RLAY) stands against other stocks under $10 that will triple. As we delve into the discussion on stocks that will triple, we must shed light on the […]
Chiesi y Gossamer Bio anuncian una colaboración global para desarrollar y comercializar seralutinib
Chiesi y Gossamer Bio anuncian una colaboración global transformadora para desarrollar y comercializar seralutinib en la hipertensión arterial pulmonar y otras...
Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple
We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other stocks under $10 that will triple. As we delve into the discussion on stocks that will triple, we must shed light on the […]
Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple
We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Nuvation Bio Inc. (NYSE:NUVB) stands against other stocks under $10 that will triple. As we delve into the discussion on stocks that will triple, we must shed light on the […]
Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple
We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against other stocks under $10 that will triple. As we delve into the discussion on stocks that will triple, we must shed light on the […]
1 Artificial Intelligence (AI) Growth Stock That Could Soar Thanks to Trump's Tariffs
Artificial intelligence stocks are sinking amid uncertainty around tariff policies.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024
GOSS Stock Earnings: Gossamer Bio Misses EPS, Misses Revenue for Q2 2024
GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
The Penny Stock Pundits: 3 Companies Poised to Become the Talk of Wall Street
Taking a small position in these penny stocks today could have you sitting on a sizable gain by the time Wall Street starts to pile in.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Chiesi und Gossamer Bio kündigen globale Zusammenarbeit zur Entwicklung und Vermarktung von Seralutinib bei pulmonaler arterieller Hypertonie sowie anderen Atemwegsindikationen an
Strategische Zusammenarbeit, um die Führungsposition von Chiesi im Bereich der Atemwege und die Entwicklungskompetenz von Gossamer Bio im Bereich der...
Chiesi et Gossamer Bio annoncent une collaboration mondiale transformatrice pour développer et commercialiser le séralutinib pour l'hypertension artérielle pulmonaire et d'autres indications respiratoires
Collaboration stratégique pour tirer parti de l'héritage de leadership dans les maladies respiratoires de Chiesi et de l'expertise de Gossamer Bio en matière...